XML 16 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (“AOCI”)
Non-controlling Interest
Beginning balance at Dec. 31, 2014 $ 448,756 $ 46 $ (53,807) $ 3,553,430 $ (3,069,241) $ 40 $ 18,288
Beginning balance (in shares) at Dec. 31, 2014   46,405,000 (5,892,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (“SARs”) and stock options 147     147      
Equity-based compensation related to deferred stock units (“DSUs”) 17     17      
Equity-based compensation related to restricted stock (“RS”) 6,655     6,655      
Issuance of DSUs 82     82      
Issuance of DSUs (in shares)   5,000          
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (3,480) $ 0   (3,480)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   198,000          
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (9)     (9)      
Exercise of SARs and stock options, net of forfeitures related to satisfying tax withholdings (in shares)   2,000          
Impact of redeemable noncontrolling interest accretion (1,303)     (1,303)      
Impact of subsidiary equity transactions 626     618     8
Repurchase of common stock (in shares)     (96,000)        
Repurchase of common stock (1,702)   $ (1,702)        
Net loss (15,857)       (14,765)   (1,092)
Ending balance at Mar. 31, 2015 433,932 $ 46 $ (55,509) 3,556,157 (3,084,006) 40 17,204
Ending balance (in shares) at Mar. 31, 2015   46,610,000 (5,988,000)        
Beginning balance at Dec. 31, 2014 $ 448,756 $ 46 $ (53,807) 3,553,430 (3,069,241) 40 18,288
Beginning balance (in shares) at Dec. 31, 2014   46,405,000 (5,892,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Repurchase of common stock (in shares) (96,277)            
Ending balance at Dec. 31, 2015 $ 357,971 $ 47 $ (55,509) 3,563,848 (3,165,321) 40 14,866
Ending balance (in shares) at Dec. 31, 2015   46,763,000 (5,988,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-based compensation expense related to stock appreciation rights (“SARs”) and stock options 58     58      
Equity-based compensation related to deferred stock units (“DSUs”) 99     99      
Equity-based compensation related to restricted stock (“RS”) 3,925     3,925      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (1,529) $ 0   (1,529)      
Issuance of RS, net of forfeitures primarily related to satisfying tax withholdings (in shares)   (346,000)          
Impact of redeemable noncontrolling interest accretion (564)     (564)      
Impact of subsidiary equity transactions $ 620     492   (74) 202
Repurchase of common stock (in shares) (470,000)   (470,000)        
Repurchase of common stock $ (4,318)   $ (4,318)        
Net loss (15,314)       (14,331)   (983)
Ending balance at Mar. 31, 2016 $ 340,948 $ 47 $ (59,827) $ 3,566,329 $ (3,179,652) $ (34) $ 14,085
Ending balance (in shares) at Mar. 31, 2016   46,417,000 (6,458,000)